Moderna’s Covid Vaccine Found 94.5% Effective in Early Analysis
A research associate works at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S. (Photographer: Adam Glanzman/Bloomberg)

Moderna’s Covid Vaccine Found 94.5% Effective in Early Analysis

(Bloomberg) -- Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharm...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.